within Pharmacolibrary.Drugs.ATC.C;

model C02KX52
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.84,
    Cl             = 4 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 0.05,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 10.200000000000001
  );

  annotation(Documentation(
    info ="<html><body><p>Ambrisentan and tadalafil is a fixed-dose combination medication approved for the treatment of pulmonary arterial hypertension (PAH) to improve exercise capacity. Ambrisentan is an endothelin receptor antagonist and tadalafil is a phosphodiesterase type 5 inhibitor. The combination is used to target different pathways involved in PAH and is currently approved for use in several regions.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for healthy adults using literature values for individual ambrisentan and tadalafil; no dedicated published population PK model for the fixed-dose combination available.</p><h4>References</h4><ol><li><p>Tanaka, S, et al., &amp; Namiki, N (2020). Simultaneous LC-MS analysis of plasma concentrations of sildenafil, tadalafil, bosentan, ambrisentan, and macitentan in patients with pulmonary arterial hypertension. <i>Die Pharmazie</i> 75(6) 236–239. DOI:<a href=&quot;https://doi.org/10.1691/ph.2020.0021&quot;>10.1691/ph.2020.0021</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/32539916/&quot;>https://pubmed.ncbi.nlm.nih.gov/32539916</a></p></li><li><p>Yokoyama, Y, et al., &amp; Itoh, K (2014). Simultaneous microdetermination of bosentan, ambrisentan, sildenafil, and tadalafil in plasma using liquid chromatography/tandem mass spectrometry for pediatric patients with pulmonary arterial hypertension. <i>Journal of pharmaceutical and biomedical analysis</i> 89 227–232. DOI:<a href=&quot;https://doi.org/10.1016/j.jpba.2013.11.007&quot;>10.1016/j.jpba.2013.11.007</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/24309556/&quot;>https://pubmed.ncbi.nlm.nih.gov/24309556</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C02KX52;
